Records containing: Neuroendocrine Neoplasm
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-08-28A Pilot Study of Pembrolizumab and Liver-Directed Therapy or Peptide Receptor Radionuclide Therapy for Patients With Well-Differentiated Neuroendocrine Tumors and Symptomatic and/or Progressive Metastases
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase 1b Trial of M3814 (Peposertib) in Combination With Lutetium 177 Dotatate for Well-Differentiated Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
-
CLINICAL_TRIALS study record update · 2026-03-19A Phase II Study of Lenvatinib in Combination With Everolimus in Patients With Advanced Carcinoid Tumors
-
CLINICAL_TRIALS study record update · 2026-03-10A Phase 1/2 Dose Escalation Study of CRN09682 With an Expansion Phase in Participants With Progressive Metastatic Somatostatin Receptor Type 2 (SST2)-Expressing Neuroendocrine Neoplasms (NENs) and Other SST2-Expressing Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-03-10Phase I Trial of MK-3475 and Concurrent Chemo/Radiation for the Elimination of Small Cell Lung Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-27The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
-
CLINICAL_TRIALS study record update · 2026-02-05PET Biodistribution Study of 68Ga-FAPI-46 in Patients With Different Malignancies: An Exploratory Biodistribution Study With Histopathology Validation
-
CLINICAL_TRIALS study record update · 2025-09-03A Pilot Study of Pembrolizumab and Liver-Directed Therapy or Peptide Receptor Radionuclide Therapy for Patients With Well-Differentiated Neuroendocrine Tumors and Symptomatic and/or Progressive Metastases
-
CLINICAL_TRIALS study record update · 2025-08-12PET Imaging Study of 68Ga-FAPI-46 Biodistribution in Cancer Patients
-
CLINICAL_TRIALS study record update · 2025-06-26A Phase I Study to Assess the Safety and Efficacy of [225Ac]Ac-DOTATATE in Patients With Inoperable, Locally Advanced or Metastatic, Progressive, Well-Differentiated,SSTR+ GEP-Nens
-
CLINICAL_TRIALS study record update · 2025-04-03Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN. REBORN Study
-
CLINICAL_TRIALS study record update · 2025-03-14Sintilimab Combined With IBI310 and Surufatinib for the Treatment of High-grade Advanced-neuroendocrine Neoplasms: a Single Arm, Open-label, Multi Center, Phase II Study
-
CLINICAL_TRIALS study record update · 2025-03-03Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial
-
CLINICAL_TRIALS study record update · 2025-02-07A Phase 1 and Pharmacokinetic Single Agent Study of Romidepsin in Patients With, Lymphomas, Chronic Lymphocytic Leukemia, and Select Solid Tumors and Varying Degrees of Liver Dysfunction
-
CLINICAL_TRIALS study record update · 2025-01-21EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Noninvasive Diagnosis of Neuroendocrine Neoplasms
-
CLINICAL_TRIALS study record update · 2025-01-13A Phase II Study of Platinum-doublet Chemotherapy in Combination With Nivolumab as First-line Treatment in Subjects With Unresectable, Locally Advanced or Metastatic G3 Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin.
-
CLINICAL_TRIALS study record update · 2024-12-19A Phase II Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PM8002 Injection in Combination With Chemotherapy as Second Line Therapy in Unresectable Neuroendocrine Neoplasm
-
CLINICAL_TRIALS study record update · 2024-12-09Dosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patients- a Randomized Study; a Step Towards Tailored PRRT
-
CLINICAL_TRIALS study record update · 2024-10-16Randomized, Double-Blinded Phase III Study of CABozantinib Versus Placebo IN Patients With Advanced NEuroendocrine Tumors After Progression on Prior Therapy (CABINET)
-
CLINICAL_TRIALS study record update · 2024-10-16Randomized, Double-Blinded Phase III Study of CABozantinib Versus Placebo IN Patients With Advanced NEuroendocrine Tumors After Progression on Prior Therapy (CABINET)
-
CLINICAL_TRIALS study record update · 2024-09-19Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2024-07-26Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
-
CLINICAL_TRIALS study record update · 2024-05-06Definition of a Multiparametric Prognostic and Predictive System of Classification of NET G3 Patients: an observAtional, Prospective Analysis of the Correlation Between Functional Imaging and Clinical Outcome (TAPIOCA)
-
CLINICAL_TRIALS study record update · 2024-03-29YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs (YOUNGSTER).
-
CLINICAL_TRIALS study record update · 2022-06-28Multicenter Phase 2 Study of Nintedanib for Patients With Advanced Carcinoid Tumors